Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Royal Prima TbkISX:PRIM +0.84%73 Piotroski F-Score is 5 as of Aug. 29, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates ISX:PRIM with a GF Score™ of 73/100 and a GF Value™ of Rp77.94 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 648 Healthcare Providers & Services companies, PT Royal Prima Tbk ranks better than 55.86% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
PT Royal Prima Tbk has an F-score of 5 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for PT Royal Prima Tbk's Piotroski F-Score or its related term are showing as below:
ISX:PRIM'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 6 Max: 8
Current: 5
During the past 12 years, the highest Piotroski F-Score of PT Royal Prima Tbk was 8. The lowest was 4. And the median was 6.
PT Royal Prima Tbk (ISX:PRIM) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
PT Royal Prima Tbk Piotroski F-Score Related Terms
PT Royal Prima Tbk Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for PT Royal Prima Tbk's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PRIM vs HCA, THC, DVA: Piotroski F-Score Comparison
For the Medical Care Facilities subindustry, PT Royal Prima Tbk's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Royal Prima Tbk Piotroski F-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Royal Prima Tbk's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where PT Royal Prima Tbk's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was -1732.587 + -15051.098 + -2212.551 + -119.664 = Rp-19,116 Mil. Cash Flow from Operations was -3708.009 + 2283.037 + 4941.31 + 5695.223 = Rp9,212 Mil. Revenue was 83488.834 + 88473.751 + 71856.391 + 76965.799 = Rp320,785 Mil. Gross Profit was 19314.982 + 12129.773 + 18691.19 + 23251.817 = Rp73,388 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(1073131.993 + 1066733.298 + 1047032.189 + 1037426.162 + 1033303.755) / 5 = Rp1051525.4794 Mil. Total Assets at the begining of this year (Jun25) was Rp1,073,132 Mil. Long-Term Debt & Capital Lease Obligation was Rp0 Mil. Total Current Assets was Rp181,104 Mil. Total Current Liabilities was Rp77,973 Mil.
Net Income was -4567.366 + -433.921 + -4466.35 + -567.351 = Rp-10,035 Mil.
Revenue was 81178.126 + 81706.017 + 80871.862 + 86071.65 = Rp329,828 Mil. Gross Profit was 17347.025 + 30451.061 + 19017.285 + 22337.803 = Rp89,153 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(1023358.937 + 1076130.457 + 1084556.03 + 1080295.807 + 1073131.993) / 5 = Rp1067494.6448 Mil. Total Assets at the begining of last year (Jun24) was Rp1,023,359 Mil. Long-Term Debt & Capital Lease Obligation was Rp0 Mil. Total Current Assets was Rp176,056 Mil. Total Current Liabilities was Rp102,408 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
PT Royal Prima Tbk's current Net Income (TTM) was -19,116.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
PT Royal Prima Tbk's return on assets of this year was -0.01781319. PT Royal Prima Tbk's return on assets of last year was -0.00980593.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
PT Royal Prima Tbk's gearing of this year was 0. PT Royal Prima Tbk's gearing of last year was 0.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
PT Royal Prima Tbk's current ratio of this year was 2.32264191. PT Royal Prima Tbk's current ratio of last year was 1.71917258.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
PT Royal Prima Tbk's number of shares in issue this year was 3393.435. PT Royal Prima Tbk's number of shares in issue last year was 3393.435.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
PT Royal Prima Tbk's gross margin of this year was 0.2287757. PT Royal Prima Tbk's gross margin of last year was 0.2703023.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
PT Royal Prima Tbk's asset turnover of this year was 0.29892388. PT Royal Prima Tbk's asset turnover of last year was 0.32229909.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
1
+
0
+
1
+
1
+
1
+
1
+
0
+
0
=
5
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
PT Royal Prima Tbk has an F-score of 5 indicating the company's financial situation is typical for a stable company.
PT Royal Prima Tbk (ISX:PRIM) has a Piotroski F-Score of 5 as of Aug. 29, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Royal Prima Tbk and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, PT Royal Prima Tbk's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, PT Royal Prima Tbk ranks #286 out of 648 companies in the Healthcare Providers & Services industry, placing it in the top 44.1%.
Is PT Royal Prima Tbk's Piotroski F-Score too high?
PT Royal Prima Tbk's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. PT Royal Prima Tbk's value of 5 is 0% at this industry median. Based on the distribution chart, PT Royal Prima Tbk ranks #286 out of 648 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Royal Prima Tbk has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Royal Prima Tbk ranks #286 out of 648 companies for Piotroski F-Score. This puts PT Royal Prima Tbk in the upper half of its industry. The industry median Piotroski F-Score is 5.00. PT Royal Prima Tbk's value of 5 is 0% at this benchmark. Historically, PT Royal Prima Tbk's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, PT Royal Prima Tbk has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Royal Prima Tbk's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Royal Prima Tbk and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Royal Prima Tbk's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp77.94, compared to a current price of Rp120.00 — trading 54% above its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Healthcare Providers & Services industry median of 5.00. PT Royal Prima Tbk's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current Piotroski F-Score is 5 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?
Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued.
The current stock price of Rp120.00 is trading 54% above its estimated GF Value™ of Rp77.94.
GuruFocus considers PT Royal Prima Tbk to be Significantly Overvalued.
Key valuation signals for ISX:PRIM:
Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
GF Value™: Rp77.94 vs. price of Rp120.00 (54% above fair value)
Industry Position: 0% at the Healthcare Providers & Services median (#286 of 648)
No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
73GF Score
Get the complete analysis for ISX:PRIM
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRIM has been successfully added to your 
